Memantine is an oral drug used for moderate to severe dementia symptoms related to Alzheimer's disease. It blocks NMDA receptors located on brain cells that release glutamate. This helps control excess glutamate activity that may contribute to neuronal damage. Memantine has minimal side effects compared to other Alzheimer's drugs. The advantages of memantine include ease of oral administration, improved cognition, behavior, ability to perform daily activities and reduced caregiver burden. Rising geriatric population, increasing prevalence of Alzheimer's disease has driven the need for treatment options like memantine. The global memantine market is driven by the rising burden of Alzheimer's disease worldwide and efficacy of memantine to manage moderate to severe dementia symptoms.
The global memantine market is estimated to be valued at US$ 921.6 Mn in 2024 and is expected to exhibit a CAGR of 5.2% over the forecast period between 2024 to 2031.
Key Takeaways
Key players operating in the memantine market are Aggregate Industries Ltd., Anglo American Plc, Atlas Roofing Corporation, BP Plc, Cemex, Chevron Corporation, Exxon Mobil Corporation, Imperial Oil Limited, Owens Corning, Petroleos de Venezuela S.A, Royal Dutch Shell plc, Shell International, Total SA, United Refining Inc.
The key driver spurring the Memantine Market Demand is the growing prevalence of Alzheimer's disease globally. As per estimates, over 55 million people were living with dementia in 2020 across the world. This number is projected to reach 78 million by 2030 and 139 million by 2050.
Technological advancements are also supporting the adoption of memantine and other adjunctive therapies for Alzheimer's disease. Researchers are exploring new formulations, delivery mechanisms and exploring memantine's potential in treating other neurological diseases to maximize its therapeutic benefits.
Market Trends
Growing geriatric demographic susceptible to Alzheimer's: The expanding global geriatric population base above 65 years of age presents a massive market opportunity. Older adults are more prone to develop Alzheimer's and dementia, driving up demand for memantine.
Increasing investment in R&D: Companies are investing aggressively in clinical trials exploring new formulations, combination therapies and studying memantine's efficacy in early-stage Alzheimer's patients. This is expected to enhance memantine's clinical profile and expand its approved therapeutic indications over time.
Market Opportunities
Combination drug therapies: There is potential to enhance memantine's efficacy through combination with other approved Alzheimer's drugs targeting different pathways like acetylcholinesterase inhibitors. This could offer improved symptom relief.
Emerging markets growth: While developed markets continue to remain major revenue generators currently, high unmet needs and healthcare infrastructure improvements in developing Asian and Latin American countries will drive future memantine market opportunities.
Impact of COVID-19 on Memantine market growth
The COVID-19 pandemic has negatively impacted the memantine market growth globally. During the initial phases of lockdown restrictions across various regions, the supply chain disruptions led to shortages of raw materials. This hampered the production volumes of memantine drug manufacturers. Hospital admissions related to Alzheimer's disease and dementia also declined as patients feared contracting the virus. However, with precautions and safety protocols in place, healthcare facilities resumed treatments gradually. Teleconsultations also helped address patient needs to some extent.
Looking ahead, healthcare providers and researchers are striving to develop new formulations and dosage forms to enhance patient adherence. Governments and industry players are collaborating to streamline supply chains and build buffer stocks. The focus remains on improving access while ensuring safety. Online platforms aim to promote awareness and support care networks. As therapies advance, the memantine market is projected to recover steadily. Once vaccines are available widely, healthcare traffic is expected to normalize. This will aid market growth prospects in the long run. Continuous monitoring of the situation and agile strategies will be crucial.
Geographical regions where memantine market concentrated in terms of value
The Memantine Market Size and Trends in terms of value is highly concentrated in North America and Europe. In the United States, neurological disorders like Alzheimer's and Parkinson's are prevalent. Due to the availability of favorable insurance and reimbursement policies, many patients have good access to prescription drugs. This has cemented the U.S. position as the largest memantine market. Germany, the U.K., France, Italy, and Spain collectively dominate the European region. The rising geriatric population suffering from dementia is a major driver here. Countries like China, Japan, India are also emerging as lucrative markets in Asia Pacific due to growing medical needs and increasing healthcare expenditures.
Fastest growing region for memantine market
The Asia Pacific region holds immense growth potential for the memantine market and is expected to witness the fastest gains during the forecast period from 2024 to 2031. Factors such as the massive patient pool, growing healthcare infrastructures, and rising disposable incomes are propelling market expansion in the Asia Pacific. Government initiatives to boost generic drug production will make memantine more affordable. Furthermore, greater awareness about Alzheimer's and neurological conditions will bolster demand. China and India, with their huge economies and populations, offer highly promising opportunities. Therefore, manufacturers are investing actively in these developing Asia Pacific countries to leverage high future returns.
Get more insights on- Memantine market
Explore More Related Article On- Lactulose Market
For Deeper Insights, Find the Report in the Language that You want
About Author:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)